High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Sher T, Dy GK, Adjei AA. Small cell lung cancer. Mayo Clinic Proceedings. 2008;83(3):355–367. doi:10.4065/83.3.355
   PubMed Web of Science ®Google Scholar
• Jordan EJ, Kim HR, Arcila ME, et al. Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies. Cancer Discov. 2017;7(6):596–609. doi:10.1158/2159-8290.CD-16-1337
   PubMed Web of Science ®Google Scholar
• Ruiz-Cordero R, Devine WP. Targeted therapy and checkpoint immunotherapy in lung cancer. Surg Pathol Clin. 2020;13(1):17–33. doi:10.1016/j.path.2019.11.002
   PubMedGoogle Scholar
• Wu P, Zheng Y, Wang Y, Wang Y, Liang N. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. J Transl Med. 2020;18(1):380. doi:10.1186/s12967-020-02545-z
   PubMed Web of Science ®Google Scholar
• Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117. doi:10.1038/s41419-017-0063-y
   PubMed Web of Science ®Google Scholar
• Santarpia M, Aguilar A, Chaib I, et al. Non-small-cell lung cancer signaling pathways, metabolism, and PD-1/PD-L1 antibodies. Cancers. 2020;12(6):1475. doi:10.3390/cancers12061475
   PubMed Web of Science ®Google Scholar
• Jin G, Wang W, Cheng P, Tian Y, Zhang L, Niu HU. DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/β-catenin signaling and p53 protein. J Biosci. 2020;45. doi:10.1007/s12038-020-00100-y
   Web of Science ®Google Scholar
• Gazy I, Kupiec M. The importance of being modified: PCNA modification and DNA damage response. Cell Cycle. 2012;11(14):2620–2623. doi:10.4161/cc.20626
   PubMed Web of Science ®Google Scholar
• Waga S, Stillman B. The DNA replication fork in eukaryotic cells. Annu Rev Biochem. 1998;67:721–751. doi:10.1146/annurev.biochem.67.1.721
   PubMed Web of Science ®Google Scholar
• Cai J, Uhlmann F, Gibbs E, et al. Reconstitution of human replication factor C from its five subunits in baculovirus-infected insect cells. Proc Natl Acad Sci U S A. 1996;93(23):12896–12901. doi:10.1073/pnas.93.23.12896
   PubMed Web of Science ®Google Scholar
• Podust VN, Podust LM, Goubin F, Ducommun B, Hübscher U. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry. 1995;34(27):8869–8875. doi:10.1021/bi00027a039
   PubMed Web of Science ®Google Scholar
• Kim J, MacNeill SA. Genome stability: a new member of the RFC family. Curr Biol. 2003;13(22):R873–875. doi:10.1016/j.cub.2003.10.048
   PubMed Web of Science ®Google Scholar
• Ohta S, Shiomi Y, Sugimoto K, Obuse C, Tsurimoto T. A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein. J Biol Chem. 2002;277(43):40362–40367. doi:10.1074/jbc.M206194200
   PubMed Web of Science ®Google Scholar
• Mayer ML, Gygi SP, Aebersold R, Hieter P. Identification of RFC(Ctf18p, Ctf8p, Dcc1p): an alternative RFC complex required for sister chromatid cohesion in S. cerevisiae. Mol Cell. 2001;7(5):959–970. doi:10.1016/S1097-2765(01)00254-4
   PubMed Web of Science ®Google Scholar
• Kouprina N, Tsouladze A, Koryabin M, Hieter P, Spencer F, Larionov V. Identification and genetic mapping of CHL genes controlling mitotic chromosome transmission in yeast. Yeast. 1993;9(1):11–19. doi:10.1002/yea.320090103
   PubMed Web of Science ®Google Scholar
• Pellegrini L. Dual roles of Ctf18-RFC: loading the clamp and angling for the polymerase. Structure. 2018;26(1):1–2. doi:10.1016/j.str.2017.12.009
   PubMed Web of Science ®Google Scholar
• Grabarczyk DB, Silkenat S, Kisker C. Structural basis for the recruitment of Ctf18-RFC to the replisome. Structure. 2018;26(1):137–144.e133. doi:10.1016/j.str.2017.11.004
   PubMed Web of Science ®Google Scholar
• Batra R, Harder N, Gogolin S, et al. Time-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown. PLoS One. 2012;7(12):e50988. doi:10.1371/journal.pone.0050988
   PubMed Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Zhang JA, Zhou XY, Huang D, et al. Development of an immune-related gene signature for prognosis in melanoma. Front Oncol. 2020;10:602555. doi:10.3389/fonc.2020.602555
   PubMed Web of Science ®Google Scholar
• Huang R, Liao X, Li Q. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia. Onco Targets Ther. 2017;10:5243–5254. doi:10.2147/OTT.S147717
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Yamaguchi R, Takahashi N, et al. Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer. PLoS One. 2014;9(1):e85750. doi:10.1371/journal.pone.0085750
   PubMed Web of Science ®Google Scholar
• Xie XW, Wang XY, Liao WJ, et al. Effect of upregulated DNA replication and sister chromatid cohesion 1 expression on proliferation and prognosis in hepatocellular carcinoma. Chin Med J. 2018;131(23):2827–2835.
   PubMed Web of Science ®Google Scholar
• Lin JJ, Riely GJ, Shaw AT. Targeting ALK: precision medicine takes on drug resistance. Cancer Discov. 2017;7(2):137–155. doi:10.1158/2159-8290.CD-16-1123
   PubMed Web of Science ®Google Scholar
• Camidge DR, Pao W, Sequist LV. Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol. 2014;11(8):473–481. doi:10.1038/nrclinonc.2014.104
   PubMed Web of Science ®Google Scholar
• Ostrem JM, Shokat KM. Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design. Nat Rev Drug Discov. 2016;15(11):771–785. doi:10.1038/nrd.2016.139
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature25183
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322. doi:10.1016/j.ccr.2012.02.022
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Al-Shibli K, Donnem T, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol. 2011;6(4):824–833. doi:10.1097/JTO.0b013e3182037b76
   PubMed Web of Science ®Google Scholar
• Caetano MS, Hassane M, Van HT, et al. Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer. Nat Commun. 2018;9(1):4589. doi:10.1038/s41467-018-07042-y
   PubMed Web of Science ®Google Scholar
• Barrera L, Montes-Servín E, Barrera A, et al. Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis. Ann Oncol. 2015;26(2):428–435. doi:10.1093/annonc/mdu549
   PubMed Web of Science ®Google Scholar
• Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798–809. doi:10.1038/nrc2734
   PubMed Web of Science ®Google Scholar
• Kortylewski M, Yu H. Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol. 2008;20(2):228–233. doi:10.1016/j.coi.2008.03.010
   PubMed Web of Science ®Google Scholar
• Xu S, Liu R, Da Y. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma. Thorac Cancer. 2018;9(8):974–988. doi:10.1111/1759-7714.12773
   PubMed Web of Science ®Google Scholar
• Shakya R, Tarulli GA, Sheng L, et al. Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer. Oncogene. 2017;36(31):4469–4480. doi:10.1038/onc.2017.66
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang J, Lian Y, et al. Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer. Mol Cancer. 2017;16(1):42. doi:10.1186/s12943-017-0612-0
   PubMed Web of Science ®Google Scholar
• Giroud M, Guard O, Dumas R. Hemiballismus from hematoma in caudate nucleus. Surg Neurol. 1985;24(5):587–588. doi:10.1016/0090-3019(85)90280-0
   PubMedGoogle Scholar
• Slotman GJ, Burchard KW, Yellin SA, Williams JJ. Prostaglandin and complement interaction in clinical acute respiratory failure. Arch Surg. 1986;121(3):271–274. doi:10.1001/archsurg.1986.01400030025002
   PubMedGoogle Scholar
• Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. N Engl J Med. 2018;378(22):2093–2104. doi:10.1056/NEJMoa1801946
   PubMed Web of Science ®Google Scholar
• Camidge DR, Doebele RC, Kerr KM. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC. Nat Rev Clin Oncol. 2019;16(6):341–355. doi:10.1038/s41571-019-0173-9
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 2017;27(11):863–875. doi:10.1016/j.tcb.2017.06.003
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang Y, Ren S, et al. Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients. Int Immunopharmacol. 2020;83:106454. doi:10.1016/j.intimp.2020.106454
   PubMed Web of Science ®Google Scholar
• Waniczek D, Lorenc Z, Śnietura M, Wesecki M, Kopec A, Muc-Wierzgoń M. Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal cancer. Arch Immunol Ther Exp. 2017;65(5):445–454. doi:10.1007/s00005-017-0463-9
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–1022. doi:10.1038/ni.2703
   PubMed Web of Science ®Google Scholar
• Halama N, Michel S, Kloor M, et al. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer Res. 2011;71(17):5670–5677. doi:10.1158/0008-5472.CAN-11-0268
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang L, Wei H, et al. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures. Int Immunopharmacol. 2020;83:106477. doi:10.1016/j.intimp.2020.106477
   PubMed Web of Science ®Google Scholar